Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
3(100.0%)
3Total
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07805447Phase 1Not Yet Recruiting

Botanical Therapy for Acute Viral Respiratory Infections

Role: lead

NCT04790240Phase 1Recruiting

Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

Role: lead

NCT04846010Phase 1Unknown

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Role: lead

All 3 trials loaded